Filgrastim restores interleukin-2 production in blood from patients with advanced human immunodeficiency virus infection

Journal of Infectious Diseases

Volumn 178, Issue 3, 1998, Pages 686-692

  Hartung, Thomas ^a   Pitrak, David L ^b   Foote, Maryann ^b   Shatzen, Edward M ^b   Verral, Stephen C ^b   Wendel, Albrecht ^b  

^a UNIVERSITY OF KONSTANZ   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; INTERLEUKIN 4; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ANTIVIRAL ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HEMATOPOIESIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0031679159     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/515338     Document Type: Article

References (7)

1. Weite K, Gabrilove J, Bronchud MH, Platzer E, Morstyn G. Filgrastim (r-metHuG-CSF): the first 10 years. Blood 1996;88:1907-29.
2. Coyle TE. Hematologic complications of human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Med Clin North Am 1997;81:449-70.
3. Moses AV, Williams S, Heneveld ML, et al. Human immunodeficiency virus infection of bone marrow endothelium reduces induction of stromal hematopoietic growth factors. Blood 1996;87:919-25.
4. Mauss S, Steinmetz HAT, Jablonowski H, Haeussinger D. Lack of induction of granulocyte colony-stimulating factor in human immunodeficiency virus-seropositive individuals. Blood 1996;88:1897-8.
5. Esser R, Glienke W, von Briesen H, Ruebsamen-Waigmann H, Andreesen R. Differential regulation of proinflammatory and hematopoietic cytokines in human macrophages after infection with human immunodeficiency virus. Blood 1996;88:3474-81.
6. Moore RD, Keruly JC, Chaisson RE. Neutropenia and bacterial infection in acquired immunodeficiency syndrome. Arch Intern Med 1996;156:1475-6.
7. Meyer CN, Skinhoj P, Prag J. Bacteremia in HIV-positive and AIDS patients: incidence, species distribution, risk-factors, outcome, and influence of long-term prophylactic antibiotic-treatment. Scand J Infect Dis 1994;26:635-42.